62642 Federal Register / Vol. 79, No. 202 / Monday, October 20, 2014 / Notices 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Anshumali Chaudhari, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1210, chaudhaa@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Drug 

Discovery for the Nervous System. 

Date: November 12, 2014. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Geoffrey G Schofield, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040–A, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1235, geoffreys@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group; 

Behavioral and Social Science Approaches to 

Preventing HIV/AIDS Study Section. 

Date: November 13–14, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Fairmont Washington, DC 

Georgetown, 2401 M Street NW., 

Washington, DC 20037. 

Contact Person: Jose H Guerrier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: November 13–14, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street 

NW., Washington, DC 20036. 

Contact Person: Arnold Revzin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4146 

MSC 7824, Bethesda, MD 20892, 301–435– 

1153. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Resource for 

X-Ray Tomography of Whole Cells. 

Date: November 16–18, 2014. 

Time: 7:00 p.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Durant, 2600 Durant Avenue, 

Berkeley, CA 94704. 

Contact Person: Paul Sammak, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

MSC 7892, Bethesda, MD 20892, 301–435– 

0601, sammakpj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Basic Research on HIV Persistence. 

Date: November 17, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The St. Regis Washington, DC, 923 

16th Street NW., Washington, DC 20006. 

Contact Person: Robert Freund, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, 301–435– 

1050, freundr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Risk, Prevention and Health 

Behavior. 

Date: November 17–18, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Martha M Faraday, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

3575, faradaym@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Basic Research on HIV Persistence. 

Date: November 17, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The St. Regis Washington, DC, 923 

16th Street NW., Washington, DC 20006. 

Contact Person: Kenneth A Roebuck, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5106, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1166, roebuckk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Oral, Dental, 

and Craniofacial Sciences SBIR/STTR. 

Date: November 18–19, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health. 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Yi-Hsin Liu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1781, liuyh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Fellowship: 

Cell Biology, Developmental Biology and 

Bioengineering. 

Date: November 18–19, 2014. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Alexander Gubin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4196, 

MSC 7812, Bethesda, MD 20892, 301–435– 

2902, gubina@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Academic 

Research Enhancement: Healthcare Delivery 

and Methodologies. 

Date: November 18, 2014. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Ping Wu, Ph.D., Scientific 

Review Officer, HDM IRG, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

Bethesda, MD 20892, 301–615–7401, wup4@

csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 14, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24785 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Omnibus 

SEP–11. 

Date: November 18, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

7W610, Rockville, MD 20850, (Telephone 

Conference Call). 

Contact Person: Caterina Bianco, MD, 

Ph.D., Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 9609 Medical Center Drive, Room 

7W610, Bethesda, MD 20892–9750, 240–276– 

6459, biancoc@mail.nih.gov. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 202 / Monday, October 20, 2014 / Notices 62643 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 14, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24786 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Interagency Autism Coordinating 

Committee Call for Nominations 

SUMMARY: The Office of the Secretary of 

the Department of Health and Human 

Services (HHS) is seeking nominations 

of individuals to serve as non-federal 

public members on the Interagency 

Autism Coordinating Committee. The 

Office of the Secretary has directed the 

Office of Autism Research Coordination 

(OARC) of the National Institute of 

Mental Health, National Institutes of 

Health to assist the Department in 

conducting an open and transparent 

nomination process. 

DATES: Nominations are due by Friday, 

November 14, 2014. 

ADDRESSES: Nominations must be sent 

to Dr. Susan Daniels, Director, Office of 

Autism Research Coordination/NIMH/

NIH, 6001 Executive Boulevard, Room 

6184, Bethesda, MD 20892 by standard 

or express mail, or via email to 

IACCPublicInquiries@mail.nih.gov. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Lina Perez, Office of Autism Research 

Coordination, National Institute of 

Mental Health via email to 

IACCPublicInquiries@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: 

Call for Nominations 

The Secretary of the Department of 

Health and Human Services (Secretary) 

is seeking nominations of individuals to 

serve as non-federal public members on 

the Interagency Autism Coordinating 

Committee (IACC), established in 

accordance with the Combating Autism 

Act of 2006 (Pub. L. 109–416) and 

reauthorized by the Autism 

Collaboration, Accountability, Research, 

Education and Support Act of 2014 

(Pub. L. 113–157). The Secretary, who 

will make the final selections and 

appointments of non-federal public 

members of the IACC, has directed the 

Office of Autism Research Coordination 

(OARC) of the National Institute of 

Mental Health to assist the Department 

in conducting an open and transparent 

nomination process. 

Eligibility 

Nominations of new non-federal 

public members are encouraged, and 

current non-federal public members 

may also be re-nominated to continue to 

serve. Self-nominations and 

nominations of other individuals are 

both permitted. Only one nomination 

per individual is required. Multiple 

nominations for the same individual 

will not increase likelihood of selection. 

The Secretary may select non-federal 

public members from the pool of 

submitted nominations and other 

sources as needed to meet statutory 

requirements and to form a balanced 

committee that represents the diversity 

within the autism spectrum disorder 

(ASD) community (details below). 

Those eligible for nomination include 

leaders or representatives of major ASD 

research, advocacy and service 

organizations, parents or guardians of 

individuals with ASD, individuals on 

the autism spectrum, healthcare and 

service providers, educators, researchers 

and other individuals with professional 

or personal experience with ASD. In 

accordance with White House Office of 

Management and Budget guidelines (FR 

Doc. 2014–19140), federally-registered 

lobbyists are not eligible. 

Committee Responsibilities 

As specified in the Committee’s 

authorizing statute (section 399CC of the 

Public Health Service Act, 42 U.S.C. 

280i–2, as amended), the Committee 

will carry out the following 

responsibilities: (1) Monitor autism 

spectrum disorder research, and to the 

extent practicable, services and support 

activities, across all relevant Federal 

departments and agencies, including 

coordination of Federal activities with 

respect to autism spectrum disorder; (2) 

develop a summary of advances in 

autism spectrum disorder research 

related to causes, prevention, treatment, 

early screening, diagnosis or ruling out 

a diagnosis; interventions, including 

school and community-based 

interventions, and access to services and 

supports for individuals with autism 

spectrum disorder; (3) make 

recommendations to the Secretary 

regarding any appropriate changes to 

such activities, including with respect 

to the strategic plan; (4) make 

recommendations to the Secretary 

regarding public participation in 

decisions relating to autism spectrum 

disorder, and the process by which 

public feedback can be better integrated 

into such decisions; (5) develop a 

strategic plan for the conduct of, and 

support for, autism spectrum disorder 

research, including, as practicable, for 

services and supports, for individuals 

with an autism spectrum disorder and 

the families of such individuals, which 

shall include (A) proposed budgetary 

requirements; and (B) recommendations 

to ensure that autism spectrum disorder 

research, and services and support 

activities to the extent practicable, of the 

Department of Health and Human 

Services and of other Federal 

departments and agencies are not 

unnecessarily duplicative; and (6) 

submit to Congress and the President: 

(A) an annual update on the summary 

of advances; and (B) an annual update 

to the strategic plan, including any 

progress made in achieving the goals 

outlined in such strategic plan. 

Committee Composition 

In accordance with the Committee’s 

authorizing statute, ‘‘Not more than 1⁄2, 

but not fewer than 1⁄3, of the total 

membership of the Committee shall be 

composed of non-Federal public 

members appointed by the Secretary.’’ 

All non-Federal public members are 

appointed as Special Government 

Employees for their service on the IACC, 

of which: 

• At least two such members shall be 

individuals with a diagnosis of autism 

spectrum disorder; 

• At least two such members shall be 

parents or legal guardians of an 

individual with an autism spectrum 

disorder; and 

• At least two such members shall be 

representatives of leading research, 

advocacy, and service organizations for 

individuals with autism spectrum 

disorder. 

The Department strives to ensure that 

the membership of HHS Federal 

advisory committees is fairly balanced 

in terms of points of view represented 

and the committee’s function. Every 

effort is made to ensure that the views 

of women, all ethnic and racial groups, 

and people with disabilities are 

represented on HHS Federal advisory 

committees and, therefore, the 

Department encourages nominations of 

qualified candidates from these groups. 

The Department also encourages 

geographic diversity in the composition 

of the Committee. Appointment to this 


tkelley on DSK3SPTVN1PROD with NOTICES